{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:30:03Z","timestamp":1792416603441,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903050"],"award-info":[{"award-number":["81903050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002667"],"award-info":[{"award-number":["82002667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20Z11900303"],"award-info":[{"award-number":["20Z11900303"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.heliyon.2023.e15159","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T12:16:13Z","timestamp":1680524173000},"page":"e15159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities"],"prefix":"10.1016","volume":"9","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5956-9328","authenticated-orcid":false,"given":"Chaofu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e15159_bib1","series-title":"World Health Organization Classification of Tumours","first-page":"356","article-title":"WHO classification of tumours of the urinary system and male genital organs","year":"2016"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15159_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world Health Organization classification of tumours of the urinary system and male genital organs-Part A: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15159_bib3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15159_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152669","article-title":"ALK-rearranged renal cell carcinomas in Polish population","volume":"215","author":"Gorczynski","year":"2019","journal-title":"Pathol. Res. Pract."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e15159_bib5","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","article-title":"ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217","volume":"33","author":"Kuroda","year":"2020","journal-title":"Mod. Pathol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15159_bib6","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15159_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/his.13185","article-title":"Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review","volume":"71","author":"Yu","year":"2017","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15159_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0b013e31824dd972","article-title":"TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients","volume":"36","author":"Sukov","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15159_bib9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-Amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"23","key":"10.1016\/j.heliyon.2023.e15159_bib10","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1158\/1078-0432.CCR-18-0269","article-title":"Therapeutic targeting of TFE3\/IRS-1\/PI3K\/mTOR Axis in translocation renal cell carcinoma","volume":"24","author":"Damayanti","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15159_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2018.03.032","article-title":"Responses to alectinib in ALK-rearranged papillary renal cell carcinoma","volume":"74","author":"Pal","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.heliyon.2023.e15159_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2019.02.008","article-title":"Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study","volume":"87","author":"Sharain","year":"2019","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15159_bib13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/his.13700","article-title":"TFE3 translocation and protein expression in renal cell carcinoma are correlated with poor prognosis","volume":"73","author":"Lee","year":"2018","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e15159_bib14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41379-019-0283-z","article-title":"Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis","volume":"32","author":"Yang","year":"2019","journal-title":"Mod. Pathol."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e15159_bib15","doi-asserted-by":"crossref","first-page":"14441","DOI":"10.1111\/jcmm.16066","article-title":"TFE3-PD-L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma","volume":"24","author":"Guo","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"22","key":"10.1016\/j.heliyon.2023.e15159_bib16","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1158\/1078-0432.CCR-19-0733","article-title":"TFEB mediates immune evasion and resistance to mTOR inhibition of renal cell carcinoma via induction of PD-L1","volume":"25","author":"Zhang","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15159_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.eururo.2020.09.027","article-title":"The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: implications in diagnosis and management","volume":"79","author":"Weng","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.heliyon.2023.e15159_bib18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.humpath.2022.06.016","article-title":"Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma","volume":"127","author":"Liu","year":"2022","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15159_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jclinpath-2020-207372","article-title":"Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey","volume":"74","author":"Akgul","year":"2021","journal-title":"J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e15159_bib20","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41379-021-00803-z","article-title":"TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma","volume":"34","author":"Wang","year":"2021","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15159_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/PAS.0b013e31827e17cb","article-title":"TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum","volume":"37","author":"Rao","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15159_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/gcc.23007","article-title":"Translocation carcinomas of the kidney","volume":"61","author":"Argani","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15159_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAP.0000000000000332","article-title":"Chameleon TFE3-translocation RCC and how gene partners can change morphology: accurate diagnosis using contemporary modalities","volume":"29","author":"Tretiakova","year":"2022","journal-title":"Adv. Anat. Pathol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e15159_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00428-022-03380-x","article-title":"TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms","volume":"481","author":"Calio","year":"2022","journal-title":"Virchows Arch."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e15159_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41379-018-0185-5","article-title":"Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile","volume":"32","author":"Sarungbam","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.heliyon.2023.e15159_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.152007","article-title":"GATA3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinoma","volume":"60","author":"Liu","year":"2022","journal-title":"Ann. Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15159_bib27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41379-020-00713-6","article-title":"TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1","volume":"34","author":"Calio","year":"2021","journal-title":"Mod. Pathol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e15159_bib28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e15159_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/gcc.22513","article-title":"Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: evidence for a specific entity with poor outcome","volume":"57","author":"Mendel","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e15159_bib30","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management","volume":"30","author":"Gupta","year":"2017","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15159_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/his.14683","article-title":"Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression","volume":"81","author":"Kammerer-Jacquet","year":"2022","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e15159_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41379-018-0128-1","article-title":"VEGFA amplification\/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations","volume":"32","author":"Calio","year":"2019","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e15159_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.2017.99","article-title":"Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays","volume":"31","author":"Skala","year":"2018","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15159_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/PAS.0000000000001408","article-title":"Clinicopathologic and molecular analysis of the TFEB fusion variant reveals new members of TFEB translocation renal cell carcinomas (RCCs): expanding the genomic spectrum","volume":"44","author":"Xia","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e15159_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41379-022-01018-6","article-title":"Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity","volume":"35","author":"Al-Obaidy","year":"2022","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e15159_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/path.5532","article-title":"Features of increased malignancy in eosinophilic clear cell renal cell carcinoma","volume":"252","author":"Nilsson","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.heliyon.2023.e15159_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.anndiagpath.2018.11.004","article-title":"Papillary pattern in clear cell renal cell carcinoma: clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases","volume":"38","author":"Alaghehbandan","year":"2019","journal-title":"Ann. Diagn. Pathol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023023666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023023666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:07:57Z","timestamp":1778598477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023023666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2405844023023666"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15159","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e15159"}}